Ethical and Integrity Challenges in Accelerated Clinical Trials: Perspectives from Key Stakeholders
Asian Journal of Ethics in Health and Medicine · 2023 · 3 (1) · 324-338
DOI: 10.51847/tlwaw8gg8a ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Ethics in Health and Medicine, 2023. Verfasst von Clàudia Pallisé Perelló und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Perelló, C. P., Inguaggiato, G., Hoven, M. V. D., Evans, N., Eck, L. V., Jong, H. K. D., Hermans, S. M., & Grobusch, M. P. (2023). Ethical and Integrity Challenges in Accelerated Clinical Trials: Perspectives from Key Stakeholders. Asian Journal of Ethics in Health and Medicine, 3(1), 324-338. https://doi.org/10.51847/tlwaw8gg8a
Vancouver
Perelló CP, Inguaggiato G, Hoven MVD, Evans N, Eck LV, Jong HKD, et al. Ethical and Integrity Challenges in Accelerated Clinical Trials: Perspectives from Key Stakeholders. Asian Journal of Ethics in Health and Medicine. 2023;3(1):324-338. doi:10.51847/tlwaw8gg8a
BibTeX
@article{Perell2023,
author = {Perelló, Clàudia Pallisé and Inguaggiato, Giulia and Hoven, Mariëtte van den and Evans, Natalie and Eck, Loïs van and Jong, Hanna K. de and Hermans, Sabine M. and Grobusch, Martin P.},
title = {Ethical and Integrity Challenges in Accelerated Clinical Trials: Perspectives from Key Stakeholders},
journal = {Asian Journal of Ethics in Health and Medicine},
year = {2023},
volume = {3},
number = {1},
pages = {324--338},
doi = {10.51847/tlwaw8gg8a}
}
EUVIMED